Cyted Health’s US Laboratory Achieves College of American Pathologists Accreditation

Cyted Health, a leading gastrointestinal molecular diagnostics company, today announces its US laboratory has achieved College of American Pathologists (CAP) accreditation, the gold standard for laboratory excellence. The accreditation builds on the laboratory’s Clinical Laboratory Improvement Amendments (CLIA) certification obtained in January 2024.

Cyted Health is presently running the DETECT-ME clinical validation study, which has been enrolling patients across multiple sites in the US since March 2025. This study will validate clinical performance of Cyted Health’s newest assays, molecular tests for the detection of esophageal conditions using EndoSign®.

“Achieving CAP accreditation reflects Cyted Health’s commitment to the highest standards in laboratory practice, recognizing our dedication to excellence and precision in detecting esophageal diseases earlier,” said Betsy Hanna, President and US General Manager, Cyted Health.

CAP accreditation is widely recognized as the industry leading benchmark for pathology and laboratory medicine. It confirms robust operational measures, technical proficiency and exemplary standards of quality assurance and control. Paired with the existing CLIA certification, regulated by the US Centers for Medicare & Medicaid Services, this accreditation further confirms Cyted Health’s laboratory practices as industry leading.